Navigation Links
TechAmerica and the Technology Association of Georgia Name Dr. Jay Yadav, CardioMEMS Founder & CEO as a Spirit of Endeavor Award Finalist
Date:11/28/2011

ATLANTA, Nov. 28, 2011 /PRNewswire/ -- CardioMEMS, Inc., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, announced today that its founder and CEO, Jay Yadav, M.D., has been recognized as a finalist for the 9th annual Spirit of Endeavor Awards in the Technology Entrepreneur category. The awards are sponsored by TechAmerica and the Technology Association of Georgia (TAG) and will be presented at a banquet on Friday, December 9, 2011 at the Twelve Hotel in Atlanta.

The Spirit of Endeavor Awards honor technology companies and individuals in Georgia and acknowledge the drive and new ideas that invigorate the community and lead to technology adoption. The Technology Entrepreneur category is specifically awarded to an individual who has brought technology to the market and demonstrates entrepreneurial achievements to the technology industry. The nominees for each award category will be presented to a panel of experts among the technology industry for selection prior to the banquet. The finalists and winners for each category will be announced and recognized at the banquet itself.

Dr. Yadav, an interventional cardiologist, founded CardioMEMS in 2000 to develop new devices to improve the management of chronic cardiovascular diseases such as heart failure. Dr. Yadav's most recent success is the Champion® Heart Failure Monitoring System, the first permanently implantable, wireless, battery-free device that provides crucial cardiac information from home for patients suffering from heart failure.  In 2010, CardioMEMS completed its clinical trial for the Champion System, demonstrating a significant reduction in heart failure related hospitalizations.

TechAmerica is partnering with the TAG Education Collaborative for the Spirit of Endeavor Awards. A portion of the proceeds will benefit the TAG-Ed program. More information on the 2011 Spirit of Endeavor Awards and the banquet on December 9 can be found at http://www.tagonline.org/Spirit-of-Endeavor.php.

About CardioMEMS, Inc.

CardioMEMS is a medical device company that has developed and is commercializing proprietary wireless sensing and communication technology for the human body. The company's technology platform is designed to improve the management of severe chronic cardiovascular diseases such as aneurysms, heart failure, and hypertension. CardioMEMS miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data, which are critical to the management of patients. The sensors are designed to be permanently implanted into the heart and blood vessels due to their small size, durability and lack of wires and batteries. Using radiofrequency (RF) energy, the sensors transmit real-time data to external electronic readers, which then communicate this information to the patient's physician. CardioMEMS developed this technology based on the belief that frequent, on-demand, real-time monitoring of vital information enables proactive patient management, which holds the promise of reducing hospitalizations, improving a patient's quality of life and delivering more efficient and cost effective health care. More information about CardioMEMS is located at www.cardiomems.com.

Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company's products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements.

CardioMEMS, Champion and the CardioMEMS logo are registered trademarks of CardioMEMS, Inc.

Caution: The Champion Heart Failure Monitoring system is an investigational device limited by federal law to investigational use.


'/>"/>
SOURCE CardioMEMS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. VIDARs Dental Film Digitizer Chosen as One of the Top 50 Technology Products for 2011
2. Montage Announces Three More Hospitals Implement Their On-Demand Search and Data Mining Technology for Radiology Studies
3. KJAYA Medical Honored with 2011 Frost & Sullivan Award for Technology Innovation in Web-based Medical Imaging Data Management
4. PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
5. Clinicians at the University of Alabama at Birmingham (UAB) Health System First in World to Use "Triggered Imaging" Technology From Varian Medical Systems
6. U.S. Patent Office Issues Notice of Allowance for Patent Application Related to CTIs GlycoPolymer Technology
7. Medical Marijuana Inc. to Acquire Biotechnology Company PharmaSphere, LLC from Converted Organics
8. AQUA® Technology Expands to Additional Digital Pathology Platform with Launch of Vectra™ 2 from Caliper Life Sciences, a Perkin-Elmer Company
9. PharmAthene to Present at the 2011 Chemical and Biological Defense Science and Technology Conference
10. Awarepoint Advances Industry Leadership with New Patented Technology
11. Intergraph® Technology Enables Bayer Technology Services to Engineer New Plant in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... --> ... Global Clinical Trials Review, H2, 2015 provides an ... trials landscape along with top level data related ... & E7), Trial Status, Trial Phase, Sponsor Type ... involved and enlists all trials (Trial title, Phase, ...
(Date:2/11/2016)... 2016 The primary goal of this research ... on the usage of liquid biopsy. Key information the ... - Timeframe of liquid biopsy adoption amidst future users ... organization type - Sample inflow to conduct liquid biopsy ... serum, and so on. - Correlation analysis of sample ...
(Date:2/11/2016)... IRVINE, Calif., Feb. 11, 2016 PRO-DEX, INC. (NasdaqCM: ... quarter ended December 31, 2015. The Company also filed its ... fiscal year 2016 with the Securities and Exchange Commission today. ... December 31, 2015 --> --> ... 2015 increased $2.6 million, or 95%, to $5.4 million from ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... ... The producers of Enterprises TV are pleased to present a ... of instantaneous consumption proves very convenient for businesses. With new technologies constantly becoming available, ... pollutes our air, water, and soil. It can also threaten the lives of man ...
(Date:2/13/2016)... ... February 13, 2016 , ... DDi , a ... Providers list for its expertise in eClinical Solutions. DDi has built its solution ... technology needs of global clients. DDi provides smarter technology for Clinical Development, Regulatory ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... 250 members of South Florida’s philanthropic community at its 10th anniversary Fashion Luncheon ...
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker ... Red Carpet Events LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and ... hydrated before the big event. The invitation-only gifting suite, held this year at the ...
(Date:2/12/2016)... Vegas, NV (PRWEB) , ... February 12, 2016 , ... ... North Las Vegas Mayor John J. Lee, Nevada Military Support Alliance president Scott Bensing, ... Fisher House at the VA Southern Nevada Healthcare System. This will be the ...
Breaking Medicine News(10 mins):